Piscataway, NJ, July 23, 2025 – Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Prucalopride Tablets [proo-KAL-oh-pride] to its growing portfolio.
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. CIC affects about 10-17% of the global population and is more commonly seen in women and older adults.
Prucalopride Tablets are available in 1 mg and 2 mg strengths in 30 count bottles.
To learn more about Prucalopride Tablets, please visit: www.camberpharma.com/prucalopride
